Pathway Analysis for Genome-Wide Association Study of Lung Cancer in Han Chinese Population

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zhang, Ruyang ^a   Zhao, Yang ^a   Chu, Minjie ^a   Wu, Chen ^b   Jin, Guangfu ^a   Dai, Juncheng ^a   Wang, Cheng ^a   Hu, Lingmin ^a   Gou, Jianwei ^a   Qian, Chen ^a   Bai, Jianling ^a   Wu, Tangchun ^c   Hu, Zhibin ^a   Lin, Dongxin ^b   Shen, Hongbing ^a   Chen, Feng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; QUALITY CONTROL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CHINA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; MALE; MODELS, GENETIC; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SIGNAL TRANSDUCTION;

EID: 84874578524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057763     Document Type: Article

References (58)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Zhang H, Cai B, (2003) The impact of tobacco on lung health in China. Respirology 8: 17-21.
3. Hu Z, Wu C, Shi Y, Guo H, Zhao X, et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 43: 792-796.
4. Dong J, Hu Z, Wu C, Guo H, Zhou B, et al. (2012) Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nat Genet 44: 895-899.
5. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637.
6. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40: 616-622.
7. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 40: 1407-1409.
8. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40: 1404-1406.
9. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747-753.
10. Maher B, (2008) Personal genomes: The case of the missing heritability. Nature 456: 18-21.
11. Moore JH, Williams SM, (2009) Epistasis and its implications for personal genetics. Am J Hum Genet 85: 309-320.
12. Pedroso I, (2010) Gaining a pathway insight into genetic association data. Methods MolBiol 628: 373-382.
13. Carlborg O, Haley CS, (2004) Epistasis: too often neglected in complex trait studies? Nat Rev Genet 5: 618-625.
14. Menashe I, Maeder D, Garcia-Closas M, Figueroa JD, Bhattacharjee S, et al. (2010) Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res 70: 4453-4459.
15. Perry JR, McCarthy MI, Hattersley AT, Zeggini E, Weedon MN, et al. (2009) Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach. Diabetes 58: 1463-1467.
16. Wang K, Li M, Bucan M, (2007) Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81: 1278-1283.
17. Wang K, Zhang H, Kugathasan S, Annese V, Bradfield JP, et al. (2009) Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet 84: 399-405.
18. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, et al. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 18: 2078-2090.
19. Zhang M, Liang L, Morar N, Dixon AL, Lathrop GM, et al. (2012) Integrating pathway analysis and genetics of gene expression for genome-wide association study of basal cell carcinoma. Hum Genet 131: 615-623.
20. Menashe I, Figueroa JD, Garcia-Closas M, Chatterjee N, Malats N, et al. (2012) Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. PLoS One 7: e29396.
21. Li D, Duell EJ, Yu K, Risch HA, Olson SH, et al. (2012) Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis 33: 1384-1390.
22. Zhang M, Liang L, Xu M, Qureshi AA, Han J, (2011) Pathway analysis for genome-wide association study of basal cell carcinoma of the skin. PLoS One 6: e22760.
23. Biernacka JM, Geske J, Jenkins GD, Colby C, Rider DN, et al. (2012) Genome-wide gene-set analysis for identification of pathways associated with alcohol dependence. Int J Neuropsychopharmacol: 1-8.
24. Chung RH, Chen YE, (2012) A two-stage random forest-based pathway analysis method. PLoS One 7: e36662.
25. Fehringer G, Liu G, Briollais L, Brennan P, Amos CI, et al. (2012) Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS One 7: e31816.
26. Wang K, Li M, Hakonarson H, (2010) Analysing biological pathways in genome-wide association studies. Nat Rev Genet 11: 843-854.
27. Li M, Yin Z, Guan P, Li X, Cui Z, et al. (2008) XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers. Lung Cancer 62: 145-151.
28. Lu J, Zhang S, Chen D, Wang H, Wu W, et al. (2009) Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. Faseb J 23: 3459-3469.
29. Guo H, Bai Y, Xu P, Hu Z, Liu L, et al. (2010) Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival. J ClinOncol 28: 1928-1935.
30. Liu B, Chen D, Yang L, Li Y, Ling X, et al. (2010) A functional variant (-1304T>G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity. Carcinogenesis 31: 1405-1411.
31. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
32. Minna JD, (2003) Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest 111: 31-33.
33. Maneckjee R, Minna JD, (1994) Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ 5: 1033-1040.
34. Maus AD, Pereira EF, Karachunski PI, Horton RM, Navaneetham D, et al. (1998) Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. MolPharmacol 54: 779-788.
35. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, et al. (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111: 81-90.
36. Egleton RD, Brown KC, Dasgupta P, (2008) Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends PharmacolSci 29: 151-158.
37. Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, et al. (2006) Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest 116: 2208-2217.
38. Miki D, Kubo M, Takahashi A, Yoon KA, Kim J, et al. (2010) Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet 42: 893-896.
39. Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD, et al. (2010) The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 6.
40. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85: 679-691.
41. Clere N, Corre I, Faure S, Guihot AL, Vessieres E, et al. (2010) Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. Int J Cancer 127: 2279-2291.
42. Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, et al. (2007) Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis. Lab Invest 87: 189-198.
43. Pickel L, Matsuzuka T, Doi C, Ayuzawa R, Maurya DK, et al. (2010) Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells. Cancer BiolTher 9.
44. Cui J, Zhang M, Zhang YQ, Xu ZH, (2007) JNK pathway: diseases and therapeutic potential. ActaPharmacol Sin 28: 601-608.
45. Wagner EF, Nebreda AR, (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
46. To CT, Tsao MS, (1998) The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). Oncol Rep 5: 1013-1024.
47. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, et al. (1997) Activating mutations for the met tyrosine kinase receptor in human cancer. ProcNatlAcadSci U S A 94: 11445-11450.
48. Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, et al. (2002) Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 13: 41-59.
49. Puri N, Salgia R, (2008) Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer. J Carcinog 7: 9.
50. Yano S, Wang W, Li Q, Matsumoto K, Sakurama H, et al. (2008) Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations. Cancer Res 68: 9479-9487.
51. Bar-Sagi D, Hall A, (2000) Ras and Rho GTPases: a family reunion. Cell 103: 227-238.
52. Vivanco I, Sawyers CL, (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
53. Palamidessi A, Frittoli E, Garre M, Faretta M, Mione M, et al. (2008) Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration. Cell 134: 135-147.
54. Zech T, Machesky L, (2008) Rab5 and rac team up in cell motility. Cell 134: 18-20.
55. Funato Y, Terabayashi T, Suenaga N, Seiki M, Takenawa T, et al. (2004) IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness. Cancer Res 64: 5237-5244.
56. Yu J, Huang NF, Wilson KD, Velotta JB, Huang M, et al. (2009) nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis. PLoS One 4: e7040.
57. Paliwal A, Vaissiere T, Krais A, Cuenin C, Cros MP, et al. (2010) Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res 70: 2779-2788.
58. Cucina A, Fuso A, Coluccia P, Cavallaro A, (2008) Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor. J Surg Res 150: 227-235.